S82363 |
PF-04971729 |
源叶(MedMol) | ≥98% |
- 提示:详情请下载说明书。
- 产品描述: Ertugliflozin (PF-04971729) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2. Has the potential for the treatment of type 2 diabetes mellitus
- 靶点: SGLT2;SGLT
- 体内研究:
Ertugliflozin (PF-04971729) reveals a concentration-dependent glucosuria after oral administration to rats
- 参考文献:
1. Mascitti V, et al. Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors. J Med Chem. 2011 Apr 28;54(8):2952-60. 2. Miao Z, et al. Pharmacokinetics, metabolism, and excretion of the antidiabetic agent ertugliflozin (PF-04971729) in healthy male subjects. Drug Metab Dispos. 2013 Feb;41(2):445-56. 3. Kalgutkar AS, et al. Preclinical species and human disposition of PF-04971729, a selective inhibitor of the sodium-dependent glucose cotransporter 2 and clinical candidate for the treatment of type 2 diabetes mellitus. Drug Metab Dispos. 2011 Sep;39(9):1609-19.
- 溶解性: Soluble in DMSO
- 保存条件: -20°C;充氩
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 2.289 ml 11.445 ml 22.89 ml 5 mM 0.458 ml 2.289 ml 4.578 ml 10 mM 0.229 ml 1.144 ml 2.289 ml 50 mM 0.046 ml 0.229 ml 0.458 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)